CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-09 | Musunuri Shankar Chief Executive Officer | Sale 10b5-1 | −468,727 | $0.95 | $445K | 4,018,470 |
| 2026-10-09 | Musunuri Shankar Chief Executive Officer | Sale 10b5-1 | −57,264 | $0.95 | $54K | 1,030,771 |
| 2026-09-09 | Musunuri Shankar Chief Executive Officer | Sale 10b5-1 | −468,727 | $1.12 | $525K | 4,487,197 |
| 2026-09-09 | Musunuri Shankar Chief Executive Officer | Sale 10b5-1 | −57,264 | $1.12 | $64K | 1,088,035 |
| 2026-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award | +3,123,201 | 4,955,924 | ||
| 2026-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +3,123,201 | 3,123,201 | ||
| 2025-01-03 | Musunuri Shankar Chief Executive Officer | Shares withheld for taxes | −177,146 | $0.89 | $158K | 1,832,723 |
| 2025-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +1,827,485 | 1,827,485 | ||
| 2024-01-03 | Musunuri Shankar Chief Executive Officer | Shares withheld for taxes | −180,204 | $0.65 | $118K | 2,009,869 |
| 2024-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +492,126 | 492,126 | ||
| 2023-02-16 | Musunuri Shankar Chief Executive Officer | Option exercise | +100,000 | $0.33 | $33K | 2,290,073 |
| 2023-02-16 | Musunuri Shankar Chief Executive Officer | Sale | −100,000 | $1.08 | $108K | 2,190,073 |
| 2023-02-16 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −100,000 | 529,764 | ||
| 2023-01-17 | Musunuri Shankar Chief Executive Officer | Option exercise | +100,000 | $0.51 | $51K | 2,327,950 |
| 2023-01-17 | Musunuri Shankar Chief Executive Officer | Sale | −100,000 | $1.28 | $128K | 2,227,950 |
| 2023-01-17 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −100,000 | 326,543 | ||
| 2023-01-03 | Musunuri Shankar Chief Executive Officer | Shares withheld for taxes | −37,877 | $1.25 | $47K | 2,190,073 |
| 2023-01-03 | Musunuri Shankar Chief Executive Officer | Grant or award | +1,475,410 | 2,227,950 | ||
| 2023-01-03 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +1,771,654 | 1,771,654 | ||
| 2022-12-16 | Musunuri Shankar Chief Executive Officer | Option exercise | +95,809 | $0.51 | $49K | 848,349 |
Page 1 of 4 · 66 trades